Download PDF
Thromb Haemost 1962; 07(01): 114-128
DOI: 10.1055/s-0038-1655460
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Coagulation Disorders in Thrombocythaemia, a Study of Seven Cases

Stefan Niewiarowski   *
1   Laboratory for Clinical Biochemistry, Institute of Hematology Warsaw, Poland (Chief: Prof. Dr. Edward Kowalski)**
,
Halina Zywicka
1   Laboratory for Clinical Biochemistry, Institute of Hematology Warsaw, Poland (Chief: Prof. Dr. Edward Kowalski)**
,
Zbigniew Latałło   **
1   Laboratory for Clinical Biochemistry, Institute of Hematology Warsaw, Poland (Chief: Prof. Dr. Edward Kowalski)**
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The blood coagulation system has been studied in 7 patients with thrombocythaemia. 4 of these patients had thrombocythaemia after splenectomy, 2 of them had thrombocythaemia associated with myeloid leukemia, and 1 thrombocythaemia associated with polycythaemia. Severe bleeding episodes were noted in 5 cases, 2 patients had only mild bleeding symptoms.

Each patient was examined several times. The period of observations varied from 2 months to 3 years. Platelet count varied from 350 000 to 3 800 000 per mm3.

Bleeding time and tourniquet test were normal in all cases. Routine coagulation and fibrinolysis studies did not reveale characteristic abnormalities in plasma clotting factors. A decrease of prothrombin complex components was observed in 4 cases. This disturbance was due to the coexisting injury of liver parenchyma or myeloid changes but not to an increase of platelets or to the abnormalities in the platelet system.

An increase of antiheparin activity was found in the plasma of 4 patients. This activity is probably due to the escape of platelet factor 4 from destroyed or qualitatively changed platelets into plasma.

Platelet clotting factors were investigated in isolated platelet suspensions, A significant decrease of platelet factor 1 was observed in all patients and a decrease of platelet factor 4 in 5 patients. In 2 cases platelet factor 4 increased. Platelet thromboplastic activity showed a great variety of disturbances in conformity with other workers observations.

Recent views on the pathogenesis of bleedings in thrombocythaemia are discussed. On the basis of their own investigations the authors suggest that the significant disturbances of platelet function may contribute to the development of bleeding, and that the increase of antiheparin activity in plasma may produce hypercoagulability and favorize the formation of thrombi.

* Present address: Research Institute of Mother and Child, Warsaw, Kasprzaka 17.


** Present address: Institute of Nuclear Research, Warsaw-Zerań.


 

  • References

  • 1 Arlolli O, Ballerini G. La patogenesi della sindromi emorragicha e tromboticha nelle trombocitemia. Haemat. Arch 1957; 42: 1279
    PubMedGoogle Scholar
  • 2 Benney W. E, Lewis F. J. W. Christmas Factor (IX) defect in a case of haemorrhagic thrombocythaemia. J. clin. Path 1959; 12: 551
    CrossrefPubMedGoogle Scholar
  • 3 Bigelow F. S. Serotonin activity in blood. Measurements in normal subjects and in patients with thrombocythaemia haemorrhagica and others haemorrhagic states. J. Lab. clin. Med 1954; 43: 759
    PubMedGoogle Scholar
  • 4 Dawson E. ABong-Hak-Hyun, Custer R. P. Evaluation of thrombocythemia by the thromboplastin generation test. Amer. J. clin. Path 1958; 29: 539
    PubMedGoogle Scholar
  • 5 Deutsch E, Wawerisch E, Franke G. über das Vorkommen eines Antiheparin-Faktors in Thrombozyten und Geweben. I. Mitteilung. Antiheparinaktivität der Thrombozyten. Thromb. Diath. haem 1957; 1: 397
    PubMedGoogle Scholar
  • 6 Duckert F, Flückiger P, Isenschmied H, Matter M, Vogel-Meng J, Koller F. A modification of the thromboplastin generation test. Acta haemat. (Basel) 1954; 12: 197
    CrossrefPubMedGoogle Scholar
  • 7 Duke W. W. The relationship of blood platelets to haemorrhagic disease. Descripition of a method for determining the bleeding time and coagulation time and report of three cases of haemorrhagic disease relieved by transfusion. J. A. M. A 1910; 55: 1185
    CrossrefPubMedGoogle Scholar
  • 8 Goedea EEpstein. Hämorrhagische Thrombozythämie bei vaskulärer Schrumpfmilz. Virchows Arch. path. Anat 1934; 292: 233
    CrossrefPubMedGoogle Scholar
  • 9 Fanger H, Cella L, Litchman K. Thrombocythemia: report of three cases and review of Literature. New Engl. J. Med 1954; 250: 456
    CrossrefPubMedGoogle Scholar
  • 10 Fountain J. R. Haemorrhagic thrombocythaemia. Report of two cases treated with radioactive phosphorus. Brit. med. J 1958; 2: 126
    CrossrefPubMedGoogle Scholar
  • 11 Goudemand M, Hutin A. Thrombocythemie essentielle. Sang 1957; 28: 267
    PubMedGoogle Scholar
  • 12 Gross R, Proll G. über Dysthrombozytosen. Klin. Wschr 1955: 1031
    PubMedGoogle Scholar
  • 13 Gunz F. W. Hemorrhagic Thrombocythemia: A critical review. Blood 1960; 15: 706
    PubMedGoogle Scholar
  • 14 Hardisty R. M, Wolf H. H. Hemorrhagic thrombocythemia: a clinical and laboratory study. Brit. J. Haemat 1955; 1: 390
    CrossrefPubMedGoogle Scholar
  • 15 Koller F, Loeliger A, Duckert F. Experiments on a new clotting factor (Factor VII). Acta haemat. (Basel) 1951; 6: 1
    CrossrefPubMedGoogle Scholar
  • 16 Kopeć M, Niewiarowski S. Czynność fibrynolityczna osocza osób zdrowych. Pol. Arch. Med. wewnęt 1956; 26: 1322
    PubMedGoogle Scholar
  • 17 Kowalski E, Kopeć M, Niewiarowski S. Evaluation of the euglobulin method of determination of fibrinolysis. J. clin. Path 1959; 12: 215
    CrossrefPubMedGoogle Scholar
  • 18 Kowarzyk H, Buluk K. Postępy badań nad krzepnięciem krwi. Postępy Hig. Med. dóśw 1950; 2: 1
    PubMedGoogle Scholar
  • 19 Larrieu M. J, Caen J, Bernard J. Inhibiteur de la coagulation d’origine plaquettaire. Etude “in vivo” et “in vitro”. Rev. Hémat 1953; 10: 719
    PubMedGoogle Scholar
  • 20 Lee R. I, White P. D. A clinical study of the coagulation time of blood. Amer. J. med. sci 1913; 145: 495
    CrossrefPubMedGoogle Scholar
  • 21 Lemaire A, Debray J, Combrisson-Le Bolloch A. Etude Clinique, cytologique et biologique d’un cas de thrombocythémie chronique avec anémie. Sang 1957; 28: 273
    PubMedGoogle Scholar
  • 22 Levin W. C, Celander D. R, Guest M. The mechanism of hemorrhagic manifestations associated with thrombocytemia. J. Lab. clin. Med 1955; 46: 930
    PubMedGoogle Scholar
  • 23 Macfarlane R. G. A simple method for measuring clot retraction. Lancet 1939; 1: 1199
    PubMedGoogle Scholar
  • 24 MacPherson A. J. S, Ingram G. I. C, MacLean N. Haemorrhagic thrombocythemia associated with cavernous transformation of the portal vein and hepatomegalia. J. roy. Coll. Surg. Edinb 1957; 2: 191
    PubMedGoogle Scholar
  • 25 Mallarmé J. Les thrombocythémies hémorragipares. Haemat. Arch 1957; 43: 1193
    PubMedGoogle Scholar
  • 26 Marchal G, Leroux M. E, Duhamel G, Samama M. Aspects thrombodynamographiques de l’hyperplaquettose dans les leucémies myéloïdes et dans les thrombocythémies hémorragiques. Sang 1956; 29: 666
    PubMedGoogle Scholar
  • 27 Marcus A. J, Spaet T. H. Platelet phosphatides: their separation, identification and clotting activity. J. clin. Invest 1958; 37: 1836
    CrossrefPubMedGoogle Scholar
  • 28 Micu S. M, Georgescu S, Safirescu F. Asupra tulbu rarilor tromboplastino formatiei la hiperplachetoze. Prob. Ter. (Bucuresti) 1959; 10: 95
    PubMedGoogle Scholar
  • 29 Niewiarowska M, Wegrzynowicz Z. Influence of dicoumarol derivatives on plasma fibrinolytic system. Thromb. Diath. haem 1959; 3: 279
    PubMedGoogle Scholar
  • 30 Niewiarowski S. L’adsorbtion des facteurs du système fibrinolytique par la bentonite. Path. Biol 1959; 7: 2557
    PubMedGoogle Scholar
  • 30a Nilsson I. M, Skanse B, BjÖrkman S. E, Scrin F. Platelet function in thrombocythemia. Acta med. scand 1960; 167: 353
    PubMedGoogle Scholar
  • 31 Paraf A, Chalut J, Caroli J. Syndromes splénopolyglobuliques et thrombocythémiques avec thromboses spléno-portales. Intérêt de la splénoportographie. Sang 1955; 26: 477
    PubMedGoogle Scholar
  • 32 Quick A. J. Hemorrhagic Diseases. Lea and Febiger; Philadelphia: 1957
    Google Scholar
  • 33 Remde W, Patzelt O, Werner R. Thrombozytose und Thrombozythämie: Symptom oder selbständiges Krankheitsbild?. Blut 1960; 6: 102
    CrossrefPubMedGoogle Scholar
  • 34 Revol L. La myélose hyperthrombocytaire. Sang 1950; 21: 409
    PubMedGoogle Scholar
  • 35 Schüpbach A, Herrman E. Thrombosekrankheit bei essentieller Thrombozytämie. Schweiz. med. Wschr 1954: 95
    PubMedGoogle Scholar
  • 36 Siede W. Hämorrhagische Diathese und Thrombozytose. Verh. dtsch. Ges. inn. Med 1952; 58: 579
    PubMedGoogle Scholar
  • 37 Soulier J. P, Larrieu M. J. étude analytique des temps de Quick allongés. Dosage de prothrombine, de proconvertine et de proaccélérine. Sang 1952; 23: 549
    PubMedGoogle Scholar
  • 38 Soulier J. P, Larrieu M. J. Nouvelle méthode de diagnostic de l’hémophilie: dosage des facteurs antihémophiliques A et B. Sang 1953; 24: 205
    PubMedGoogle Scholar
  • 39 Soulier J. P, Larrieu M. J, Wartelle O. La thromboplastinoformation dans les affections plaquettaires. Acta haemat. (Basel) 1955; 14: 160
    CrossrefPubMedGoogle Scholar
  • 40 Soulier J. P, Alagille D, Larrieu M. J. Physiopathologie des hémorragies en cours des hyperplaquettoses. Sang 1957; 28: 275
    PubMedGoogle Scholar
  • 41 Spaet T. H. Anticoagulants derived from blood platelets. J. appl. Physiol 1957; 11: 119
    CrossrefPubMedGoogle Scholar
  • 42 Spaet T. H, Bauer S, Melamed S. Hemorrhagic thrombocythemia. A blood coagulation disorder. Arch. int. Med 1956; 98: 377
    CrossrefPubMedGoogle Scholar
  • 43 Spangberg J, Zettergren L. Case of thrombocythemia essentialis. Acta med. scand 1949; 135: 176
    PubMedGoogle Scholar
  • 44 Uotila U. On hemorrhagic thrombocythemia. Acta med. scand 1938; 95: 136
    PubMedGoogle Scholar
  • 45 Waaler B. A. Contact activation in the intrinsic blood clotting system. Scand. J. clin. Lab. Invest. (suppl.) 1959; 11 (37) 135
    PubMedGoogle Scholar
  • 46 Wolf P. A modification for routine laboratory use of Stefanini’s method for estimation of Factor V in human oxalated plasma. J. clin. Path 1953; 6: 34
    CrossrefPubMedGoogle Scholar
  • 47 Zucker M. B, Borrelli J. Concentration of serotonin in serum in thrombocytopathia, pseudohemophilia and thrombocytosis. Amer. J. clin. Path 1956; 26: 13
    PubMedGoogle Scholar